You’ve seen the headlines and heard the name, now find out more about the latest in gene therapy, CRISPR/Cas9, and what these technologies could mean for Duchenne during three different opportunities that promise to provide an in-depth analysis:
- Gene Therapy and CRISPR Cas9: Similarities and differences, Tuesday June 28 from 12:45-2:00pm eastern live from PPMD’s Annual Connect Conference. Visit our conference page for streaming information.
- On Wednesday, July 13 at 1pm eastern, PPMD welcomes Dr. Eric Olson from the Department of Molecular Biology at UT Southwestern Medical Center to discuss the basics of gene editing and the potential permanent correction of Duchenne mutations with CRISPR/Cas9. View the webinar details.
- On Friday, August 26 from 9.30-3.30pm, UT Southwestern will be hosting a Clinical DMD Symposium that is designed to update Duchenne patients and their families on the role of genome editing as a potential therapy for Duchenne as well as provide an update on the standard of care for management of Duchenne. The symposium will be streamed live and the shared on the UTSW Wellstone website. PPMD will keep you updated with links and exact details closer to the time.